Meda 'looking for acquisitions' as Mylan looks on
This article was originally published in Scrip
Executive Summary
Swedish firm Meda, which is being stalked by US generics company Mylan, is increasing its search for an acquisition target, rather than readying itself to be acquired. The firm has twice rejected bids from Mylan in recent weeks (scripintelligence.com, 29 April 2014; 4 April 2014)